Abstract—
Each neuron has 100–10000 connections (synapses) with other neural cells, therefore genome pathologies affecting a small proportion of brain cells are capable of causing dysfunction of the entire central nervous system (CNS). Recently, genome and chromosome instability has been uncovered in neurodegeneration (Alzheimer’s disease, ataxia telangiectasia). Somatic tissue-specific mosaicism was observed in the brain of individuals with neuropsychiatric diseases including schizophrenia, autism, intellectual disability, and epilepsy. The study of genetic processes in neurons allows determination of a certain number of genetic pathways and candidate processes, modifications of which can cause impaired genome stability. Brain-specific somatic mutations generally occur at the earliest stages of development. Accordingly, genome variability and somatic mosaicism are expected to be mediated by cell cycle regulation, DNA repair, DNA replication, and programmed cell death in the brain. Endomitosis, endoreduplication, and abortive entrance to the cell cycle are also commonly observed in neurodegeneration. Brain-specific genome instability may be a key element in the pathogenic cascade of neurodegeneration. Here we review the current state of knowledge concerning somatic genome variations in neurodegenerative and psychiatric diseases and analyze the causes and consequences of genomic instability in the CNS.
Similar content being viewed by others
REFERENCES
McGuffin P., Owen M.J., Gottesman I.I. 2002. Psychiatric Genetics and Genomics. Oxford, UK: Oxford Univ. Press.
Lee J.A., Lupski J.R. 2006. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron. 52, 103–121.
Iourov I.Y., Vorsanova S.G., Yurov Y.B. 2008. Molecular cytogenetics and cytogenomics of brain diseases. Curr. Genomics. 9, 452–465.
Parikshak N.N., Gandal M.J., Geschwind D.H. 2015. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat. Rev. Genet. 16, 441–458.
Smoller J.W., Andreassen O.A., Edenberg H.J., Faraone S.V., Glatt S.J., Kendler K.S. 2019. Psychiatric genetics and the structure of psychopathology. Mol. Psychiatry. 24, 409–420.
Kingsbury M.A., Yung Y.C., Peterson S.E., Westra J.W., Chun J. 2006. Aneuploidy in the normal and diseased brain. Cell. Mol. Life Sci. 63, 2626–2641.
Iourov I.Y., Vorsanova S.G., Yurov Y.B. 2006. Chromosomal variation in mammalian neuronal cells: Known facts and attractive hypotheses. Int. Rev. Cytol. 249, 143–191.
Kingsbury M.A., Friedman B., McConnell M.J., Rehen S.K., Yang A.H., Kaushal D., Chun J. 2005. Aneuploid neurons are functionally active and integrated into brain circuitry. Proc. Natl. Acad. Sci. U. S. A. 102, 6143–6147.
Mosch B., Morawski M., Mittag A., Lenz D., Tarnok A., Arendt T. 2007. Aneuploidy and DNA replication in the normal human brain and Alzheimer’s disease. J. Neurosci. 27, 6859–6867.
Iourov I.Y., Vorsanova S.G., Liehr T., Yurov Y.B. 2009. Aneuploidy in the normal, Alzheimer’s disease and ataxia-telangiectasia brain: Differential expression and pathological meaning. Neurobiol. Dis. 34, 212–220.
Knouse K.A., Wu J., Whittaker C.A., Amon A. 2014. Single cell sequencing reveals low levels of aneuploidy across mammalian tissues. Proc. Natl. Acad. Sci. U. S. A. 111, 13409–13414.
Iourov I.Y., Vorsanova S.G., Liehr T., Kolotii A.D., Yurov Y.B. 2009. Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain. Hum. Mol. Genet. 18, 2656–2669.
Arendt T., Brückner M.K., Mosch B., Lösche A. 2010). Selective cell death of hyperploid neurons in Alzheimer’s disease. Am. J. Pathol. 177, 15–20.
Yurov Y.B., Vorsanova S.G., Iourov I.Y. 2010. Ontogenetic variation of the human genome. Curr. Genomics. 11, 420–425.
Zhang L., Vijg J. 2018. Somatic mutagenesis in mammals and its implications for human disease and aging. Annu. Rev. Genet. 52, 397–419.
Kennedy S.R., Loeb L.A., Herr A.J. 2012. Somatic mutations in aging, cancer and neurodegeneration. Mech. Ageing Dev. 133, 118–126.
Varetti G., Pellman D., Gordon D.J. 2014. Aurea mediocritas: The importance of a balanced genome. Cold Spring Harb. Perspect. Biol. 6, a015842.
Mitrentsi I., Yilmaz D., Soutoglou E. 2020. How to maintain the genome in nuclear space. Curr. Opin. Cell Biol. 64, 58–66.
Herrup K., Yang Y. 2007. Cell cycle regulation in the postmitotic neuron: Oxymoron or new biology? Nat. Rev. Neurosci. 8, 368–378.
Arendt T. 2012. Cell cycle activation and aneuploid neurons in Alzheimer’s disease. Mol. Neurobiol. 46, 125–135.
Iourov I.Y., Vorsanova S.G., Yurov Y.B. 2013. Somatic cell genomics of brain disorders: A new opportunity to clarify genetic–environmental interactions. Cytogenet. Genome Res. 139, 181–188.
Muotri A.R., Gage F.H. 2006. Generation of neuronal variability and complexity. Nature. 441, 1087–1093.
Herculano-Houzel S. 2009. The human brain in numbers: A linearly scaled-up primate brain. Front. Hum. Neurosci. 3, 31.
Yurov Y.B., Iourov I.Y., Monakhov V.V., Soloviev I.V., Vostrikov V.M., Vorsanova S.G. 2005. The variation of aneuploidy frequency in the developing and adult human brain revealed by an interphase FISH study. J. Histochem. Cytochem. 53, 385–390.
Yurov Y.B., Iourov I.Y., Vorsanova S.G., Liehr T., Kolotii A.D., Kutsev S.I., Pellestor F., Beresheva A.K., Demidova I.A., Kravets V.S., Monakhov V.V., Soloviev I.V. 2007. Aneuploidy and confined chromosomal mosaicism in the developing human brain. PLoS One. 2, e558.
Rohrback S., April C., Kaper F., Rivera R.R., Liu C.S., Siddoway B., Chun J. 2018. Submegabase copy number variations arise during cerebral cortical neurogenesis as revealed by single-cell whole-genome sequencing. Proc. Natl. Acad. Sci. U. S. A. 115, 10804–10809.
Rohrback S., Siddoway B., Liu C.S., Chun J. 2018. Genomic mosaicism in the developing and adult brain. Dev. Neurobiol. 78, 1026–1048.
Yurov Y.B., Vorsanova S.G., Iourov I.Y. 2018. Human molecular neurocytogenetics. Curr. Genet. Med. Rep. 6, 155–164.
Bushman D.M., Chun J. 2013. The genomically mosaic brain: Aneuploidy and more in neural diversity and disease. Semin. Cell. Dev. Biol. 24, 357–369.
Gawad C., Koh W., Quake S.R. 2016. Single-cell genome sequencing: Current state of the science. Nat. Rev. Genet. 17, 175–188.
Muyas F., Zapata L., Guigó R., Ossowski S. 2020. The rate and spectrum of mosaic mutations during embryogenesis revealed by RNA sequencing of 49 tissues. Genome Med. 12, 49.
Fricker M., Tolkovsky A.M., Borutaite V., Coleman M., Brown G.C. 2018. Neuronal cell death. Physiol. Rev. 98, 813–880.
McConnell M.J., Lindberg M.R., Brennand K.J., Piper J.C., Voet T., Cowing-Zitron C., Shumilina S., Lasken R.S., Vermeesch J.R., Hall I.M., Gage F.H. 2013. Mosaic copy number variation in human neurons. Science. 342, 632–637.
Kaushal D., Contos J.J., Treuner K., Yang A.H., Kingsbury M.A., Rehen S.K., McConnell M.J., Okabe M., Barlow C., Chun J. 2003. Alteration of gene expression by chromosome loss in the postnatal mouse brain. J. Neurosci. 23, 5599–5606.
Yang A.H., Kaushal D., Rehen S.K., Kriedt K., Kingsbury M.A., McConnell M.J., Chun J. 2003. Chromosome segregation defects contribute to aneuploidy in normal neural progenitor cells. J. Neurosci. 23, 10454–10462.
Zupanc G.K. 2009. Towards brain repair: Insights from teleost fish. Semin. Cell. Dev. Biol. 20, 683–690.
Andriani G.A., Vijg J., Montagna C. 2017. Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain. Mech. Ageing Dev. 161, 19–36.
Vijg J., Dong X., Milholland B., Zhang L. 2017. Genome instability: A conserved mechanism of ageing? Essays Biochem. 61, 305–315.
Iourov I.Y., Vorsanova S.G., Yurov Y.B., Kutsev S.I. 2019. Ontogenetic and pathogenetic views on somatic chromosomal mosaicism. Genes (Basel). 10, E379.
Fischer H.G., Morawski M., Brückner M.K., Mittag A., Tarnok, A., Arendt T. 2012. Changes in neuronal DNA content variation in the human brain during aging. Aging Cell. 11, 628–633.
Van den Bos H., Spierings D.C., Taudt A.S., Bakker B., Porubský D., Falconer E., Novoa C., Halsema N., Kazemier H.G., Hoekstra-Wakker K., Guryev V., den Dunnen W.F., Foijer F., Tatché M.C., Boddeke H.W., Lansdorp P.M. 2016. Single-cell whole genome sequencing reveals no evidence for common aneuploidy in normal and Alzheimer’s disease neurons. Genome Biol. 17, 116.
Chronister W.D., Burbulis I.E., Wierman M.B., Wolpert M.J., Haakenson M.F., Smith A.C.B., Kleinman J.E., Hyde T.M., Weinberger D.R., Bekiranov S., McConnell M.J. 2019. Neurons with complex karyotypes are rare in aged human neocortex. Cell Rep. 26, 825–835.e7.
Iourov I.Y., Liehr T., Vorsanova S.G., Kolotii A.D., Yurov Y.B. 2006. Visualization of interphase chromosomes in postmitotic cells of the human brain by multicolour banding (MCB). Chromosome Res. 14, 223–229.
Faggioli F., Vijg J., Montagna C. 2011. Chromosomal aneuploidy in the aging brain. Mech. Ageing Dev. 132, 429–436.
Andriani G.A., Maggi E., Piqué D., Zimmerman S.E., Lee M., Quispe-Tintaya W., Maslov A., Campisi J., Vijg J., Mar J.C., Montagna C. 2019. A direct comparison of interphase FISH versus low-coverage single cell sequencing to detect aneuploidy reveals respective strengths and weaknesses. Sci. Rep. 9, 10508.
Iourov I.Y., Vorsanova S.G., Yurov Y.B. 2012. Single cell genomics of the brain: Focus on neuronal diversity and neuropsychiatric diseases. Curr. Genomics. 13, 477–488.
Potter H., Chial H.J., Caneus J., Elos M., Elder N., Borysov S., Granic A. 2019. Chromosome instability and mosaic aneuploidy in neurodegenerative and neurodevelopmental disorders. Front. Genet. 10, 1092.
Tiganov A.S., Yurov Yu.B., Vorsanova S.G., Iourov I.Yu. 2012. Brain genome instability: Etiology, pathogenesis, and new biological markers of mental illness. Vestn. Ross. Akad. Med. Nauk. 9, 45–53.
Graham E.J., Vermeulen M., Vardarajan B., Bennett D., De Jager P., Pearse R.V. 2nd, Young-Pearse T.L., Mostafavi S. 2019. Somatic mosaicism of sex chromosomes in the blood and brain. Brain Res. 1721, 146345.
Pluvinage J.V., Wyss-Coray T. 2020. Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration. Nat. Rev. Neurosci. 21, 93–102.
Leija-Salazar M., Piette C., Proukakis C. 2018. Somatic mutations in neurodegeneration. Neuropathol. Appl. Neurobiol. 44, 267–285.
Shepherd C.E., Yang Y., Halliday G.M. 2018. Region- and cell-specific aneuploidy in brain aging and neurodegeneration. Neuroscience. 374, 326–334.
Coppedè F., Migliore L. 2015. DNA damage in neurodegenerative diseases. Mutat. Res. 776, 84–97.
Lin X., Kapoor A., Gu Y., Chow M.J., Peng J., Zhao K., Tang D. 2020. Contributions of DNA damage to Alzheimer’s disease. Int. J. Mol. Sci. 21, 1666.
Yurov Y.B., Vorsanova S.G., Iourov I.Y. 2011. The DNA replication stress hypothesis of Alzheimer’s disease. Sci. World J. 11, 2602–2612.
Granic A., Potter H. 2013. Mitotic spindle defects and chromosome mis-segregation induced by LDL/cholesterol-implications for Niemann–Pick C1, Alzheimer’s disease, and atherosclerosis. PLoS One. 8, e60718.
Bajic V., Spremo-Potparevic B., Zivkovic L., Isenovic E.R., Arendt T. 2015. Cohesion and the aneuploid phenotype in Alzheimer’s disease: A tale of genome instability. Neurosci. Biobehav. Rev. 55, 365–374.
Nudelman K.N.H., McDonald B.C., Lahiri D.K., Saykin A.J. 2019. Biological hallmarks of cancer in Alzheimer’s disease. Mol. Neurobiol. 56, 7173–7187.
Fielder E., von Zglinicki T., Jurk D. 2017. The DNA damage response in neurons: Die by apoptosis or survive in a senescence-like state? J. Alzheimers Dis. 60, S107–S131.
Baker D.J., Petersen R.C. 2018. Cellular senescence in brain aging and neurodegenerative diseases: Evidence and perspectives. J. Clin. Invest. 128, 1208–1216.
Yurov Y.B., Vorsanova S.G., Liehr T., Kolotii A.D., Iourov I.Y. 2014. X chromosome aneuploidy in the Alzheimer’s disease brain. Mol. Cytogenet. 7, 20.
Granic A., Padmanabhan J., Norden M., Potter H. 2010. Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: Requirement for tau and APP. Mol. Biol. Cell. 21, 511–520.
Lee M.H., Siddoway B., Kaeser G.E., Segota I., Rivera R., Romanow W.J., Liu C.S., Park C., Kennedy G., Long T., Chun J. 2018. Somatic APP gene recombination in Alzheimer’s disease and normal neurons. Nature. 563, 639–645.
Iourov I.Y., Vorsanova S.G., Yurov Y.B. 2011. Genomic landscape of the Alzheimer’s disease brain: Chromosome instability—aneuploidy, but not tetraploidy—mediates neurodegeneration. Neurodegener. Dis. 8, 35–37.
Sala Frigerio C., Lau P., Troakes C., Deramecourt V., Gele P., Van Loo P., Voet T., De Strooper B. 2015. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer’s disease patients. Alzheimer’s Dement. 11, 1265–1276.
Caneus J., Granic A., Rademakers R., Dickson D.W., Coughlan C.M., Chial H.J., Potter H. 2018. Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations. Mol. Biol. Cell. 29, 575–586.
Yang Y., Shepherd C., Halliday G. 2015. Aneuploidy in Lewy body diseases. Neurobiol. Aging. 36, 1253–1260.
Mokretar K., Pease D., Taanman J.W., Soenmez A., Ejaz A., Lashley T., Ling H., Gentleman S., Houlden H., Holton J.L., Schapira A.H.V., Nacheva E., Proukakis C. 2018. Somatic copy number gains of α‑synuclein (SNCA) in Parkinson’s disease and multiple system atrophy brains. Brain. 141, 2419–2431.
Hou Y., Song H., Croteau D.L., Akbari M., Bohr V.A. 2017. Genome instability in Alzheimer disease. Mech. Ageing Dev. 161, 83–94.
Yurov Y.B., Vorsanova S.G., Iourov I.Y. 2019. Chromosome instability in the neurodegenerating brain. Front. Genet. 10, 892.
McConnell M.J., Moran J.V., Abyzov A., Akbarian S., Bae T., Cortes-Ciriano I., Erwin J.A., Fasching L., Flasch D.A., Freed D., Ganz J., Jaffe A.E., Kwan K.Y., Kwon M., Lodato M.A., et al. 2017. Intersection of diverse neuronal genomes and neuropsychiatric disease: The brain somatic mosaicism network. Science. 356, eaal1641.
D’Gama A.M., Walsh C.A. 2018. Somatic mosaicism and neurodevelopmental disease. Nat. Neurosci. 21, 1504–1514.
Yurov Y.B., Vostrikov V.M., Vorsanova S.G., Monakhov V.V., Iourov I.Y. 2001. Multicolor fluorescent in situ hybridization on post-mortem brain in schizophrenia as an approach for identification of low-level chromosomal aneuploidy in neuropsychiatric diseases. Brain Dev. 23, S186–S190.
Yurov Y.B., Iourov I.Y., Vorsanova S.G., Demidova I.A., Kravetz V.S., Beresheva A.K., Kolotii A.D., Monakchov V.V., Uranova N.A., Vostrikov V.M., Soloviev I.V., Liehr T. 2008. The schizophrenia brain exhibits low-level aneuploidy involving chromosome 1. Schizophr. Res. 98, 139–147.
Yurov Y.B., Vorsanova S.G., Demidova I.A., Kolotii A.D., Soloviev I.V., Iourov I.Y. 2018. Mosaic brain aneuploidy in mental illnesses: An association of low-level post-zygotic aneuploidy with schizophrenia and comorbid psychiatric disorders. Curr. Genomics. 19, 163–172.
Fullard J.F., Charney A.W., Voloudakis G., Uzilov A.V., Haroutunian V., Roussos P. 2019. Assessment of somatic single-nucleotide variation in brain tissue of cases with schizophrenia. Transl. Psychiatry. 9, 21.
Kim J., Shin J.Y., Kim J.I., Seo J.S., Webster M.J., Lee D., Kim S. 2014. Somatic deletions implicated in functional diversity of brain cells of individuals with schizophrenia and unaffected controls. Sci. Rep. 4, 3807.
Sakai M., Watanabe Y., Someya T., Araki K., Shibuya M., Niizato K., Oshima K., Kunii Y., Yabe H., Matsumoto J., Wada A., Hino M., Hashimoto T., Hishimoto A., Kitamura N., et al. 2015. Assessment of copy number variations in the brain genome of schizophrenia patients. Mol. Cytogenet. 8, 46.
Smith C.L., Bolton A., Nguyen G. 2010. Genomic and epigenomic instability, fragile sites, schizophrenia and autism. Curr Genomics. 11, 447-469.
Yurov Yu.B., Vorsanova S.G., Demidova I.A., Kravets V.S., Vostrikov V.M., Solov’ev I.V., Uranova N.A., Iourov I.Yu. 2016. Genome instability in brain cells: Chromosomal mosaicism in schizophrenia. Zh. Nevropatol. Psikhiatrii im. S.S. Korsakova. 116, 86–91.
Ye C.J., Regan S., Liu G., Alemara S., Heng H.H. 2018. Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems. Mol. Cytogenet. 11, 31.
Vorsanova S.G., Yurov Yu.B., Sil’vanovich A.P., Demidova I.A., Iourov I.Yu. 2013. Modern concepts of molecular genetics and genomics of autism. Fundament. Issled. 4, 356–367.
Castellani C.A., Arking D.E. 2020. High-risk, high-reward genetics in ASD. Neuron. 105, 407–410.
Yurov Y.B., Vorsanova S.G., Iourov I.Y., Demidova I.A., Beresheva A.K., Kravetz V.S., Monakhov V.V., Kolotii A.D., Voinova-Ulas V.Y., Gorbachevskaya N.L. 2007. Unexplained autism is frequently associated with low-level mosaic aneuploidy. J. Med. Genet. 44, 521–525.
Biesecker L.G., Spinner N.B. 2013. A genomic view of mosaicism and human disease. Nat. Rev. Genet. 14, 307–320.
D’Gama A.M., Pochareddyk S., Li M., Jamuar S.S., Reiff R.E., Lam A.N., Sestan N., Walsh C.A. 2015. Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms. Neuron. 88, 910–917.
Koh H.Y., Lee J.H. 2018. Brain somatic mutations in epileptic disorders. Mol. Cells. 41, 881–888.
Park S.M., Lim J.S., Ramakrishina S., Kim S.H., Kim W.K., Lee J., Kang H.C., Reiter J.F., Kim D.S., Kim H.H., Lee J.H. 2018. Brain somatic mutations in MTOR disrupt neuronal ciliogenesis, leading to focal cortical dyslamination. Neuron. 99, 83–97.e7.
Ye Z., McQuillan L., Poduri A., Green T.E., Matsumoto N., Mefford H.C., Scheffer I.E., Berkovic S.F., Hildebrand M.S. 2019. Somatic mutation: The hidden genetics of brain malformations and focal epilepsies. Epilepsy Res. 155, 106161.
Liu G., Ye C.J., Chowdhury S.K., Abdallah B.Y., Horne S.D., Nichols D., Heng H.H. 2018. Detecting chromosome condensation defects in gulf war illness patients. Curr. Genomics. 19, 200–206.
Vorsanova S.G., Zelenova M.A., Yurov Y.B., Iourov I.Y. 2018. Behavioral variability and somatic mosaicism: A cytogenomic hypothesis. Curr. Genomics. 19, 158–162.
Okazaki S., Boku S., Otsuka I., Mouri K., Aoyama S., Shiroiwa K., Sora I., Fujita A., Shirai Y., Shirakawa O., Kokai M., Hishimoto A. 2016. The cell cycle-related genes as biomarkers for schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 70, 85–91.
Yang J., Yan B., Fan Y., Yang L., Zhao B., Zhu F., Zheng J., Wang W., Bai L., Zhang F., Ma X. 2019. Identification of schizophrenia related biological pathways across eight brain regions. Behav. Brain Res. 360, 1–6.
Fan Y., Abrahamsen G., McGrath J.J., Mackay-Sim A. 2012. Altered cell cycle dynamics in schizophrenia. Biol. Psychiatry. 71, 129–135.
Pramparo T., Lombardo M.V., Campbell K., Barnes C.C., Marinero S., Solso S., Young J., Mayo M., Dale A., Ahrens-Barbeau C., Murray S.S., Lopez L., Lewis N., Pierce K., Courchesne E. 2015. Cell cycle networks link gene expression dysregulation, mutation, and brain maldevelopment in autistic toddlers. Mol. Syst. Biol. 11, 841.
Gumusoglu S.B., Hing B.W.Q., Chilukuri A.S.S., Dewitt J.J., Scroggins S.M., Stevens H.E. 2020. Chronic maternal interleukin-17 and autism-related cortical gene expression, neurobiology, and behavior. Neuropsychopharmacology. 45, 1008–1017.
Wei H., Alberts I., Li X. 2014. The apoptotic perspective of autism. Int. J. Dev. Neurosci. 36, 13–18.
Pan L., Penney J., Tsai L.H. 2014. Chromatin regulation of DNA damage repair and genome integrity in the central nervous system. J. Mol. Biol. 426, 3376–3388.
Paquola A.C.M., Erwin J.A., Gage F.H. 2017. Insights into the role of somatic mosaicism in the brain. Curr. Opin. Syst. Biol. 1, 90–94.
LiCausi F., Hartman N.W. 2018. Role of mTOR complexes in neurogenesis. Int. J. Mol. Sci. 19, 1544.
Ziats C.A., Rennert O.M., Ziats M.N. 2019. Toward a pathway-driven clinical-molecular framework for classifying autism spectrum disorders. Pediatr. Neurol. 98, 46–52.
Putnam C.D., Allen-Soltero S.R., Martinez S.L., Chan J.E., Hayes T.K., Kolodner R.D. 2012. Bioinformatic identification of genes suppressing genome instability. Proc. Natl. Acad. Sci. U. S. A. 109, E3251–E3259.
Iourov I.Y., Vorsanova S.G., Zelenova M.A., Korostelev S.A., Yurov Y.B. 2015. Genomic copy number variation affecting genes involved in the cell cycle pathway: Implications for somatic mosaicism. Int. J. Genomics. 2015, 757680.
Sugaya K. 2019. Chromosome instability caused by mutations in the genes involved in transcription and splicing. RNA Biol. 16, 1521–1525.
Crawley J.N., Heyer W.D., LaSalle J.M. 2016. Autism and cancer share risk genes, pathways, and drug targets. Trends Genet. 32, 139–146.
Markkanen E., Meyer U., Dianov G.L. 2016. DNA damage and repair in schizophrenia and autism: Implications for cancer comorbidity and beyond. Int. J. Mol. Sci. 17, 856.
Ho J., Cruise E.S., Dowling R.J.O., Stambolic V. 2020. PTEN nuclear functions. Cold Spring Harb. Perspect Med. 10, a036079.
Erickson R.P. 2010. Somatic gene mutation and human disease other than cancer: An update. Mutat. Res. 705, 96–106.
Iourov I.Y., Vorsanova S.G., Yurov Y.B. 2010. Somatic genome variations in health and disease. Curr. Genomics. 11, 387–396.
Campbell I.M., Shaw C.A., Stankiewicz P., Lupski J.R. 2015. Somatic mosaicism: Implications for disease and transmission genetics. Trends Genet. 31, 382–392.
Wang L., Zhou K., Fu Z., Yu D., Huang H., Zang X., Mo X. 2017. Brain development and Akt signaling: The crossroads of signaling pathway and neurodevelopmental diseases. J. Mol. Neurosci. 61, 379–384.
Thadathil N., Hori R., Xiao J., Khan M.M. 2019. DNA double-strand breaks: A potential therapeutic target for neurodegenerative diseases. Chromosome Res. 27, 345–364.
Hussain R., Zubair H., Pursell S., Shahab M. 2018. Neurodegenerative diseases: Regenerative mechanisms and novel therapeutic approaches. Brain Sci. 8, 177.
Howell K.R., Law A.J. 2020. Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development. Schizophr. Res. 217, 95–104.
Martínez-Cué C., Rueda N. 2020. Cellular senescence in neurodegenerative diseases. Front. Cell. Neurosci. 14, 16.
Wilhelm T., Said M., Naim V. 2020. DNA replication stress and chromosomal instability: dangerous liaisons. Genes (Basel). 11, E642.
Dyuzhikova N.A., Daev E.V. 2018. The genome and stress response in animals and humans. Ekol. Genet. 16, 4–26.
Horne S.D., Chowdhury S.K., Heng H.H. 2014. Stress, genomic adaptation, and the evolutionary trade-off. Front. Genet. 5, 92.
Reznik A.M., Kostyuk G.P., Khannanova A.N. 2016. Problems of genetic prerequisites of schizophrenia. Sotsial. Klin. Psikhiatriya. 26, 101–108.
Puzyrev V.P. 2014. Medical pathogenetics. Vavilov. Zh. Genet. Selekts. 18, 7–21.
Iourov I.Y., Vorsanova S.G., Yurov Y.B. 2019. The variome concept: Focus on CNVariome. Mol. Cytogenet. 12, 52.
Vorsanova S.G., Yurov Y.B., Iourov I.Y. 2020. Dynamic nature of somatic chromosomal mosaicism, genetic-environmental interactions and therapeutic opportunities in disease and aging. Mol. Cytogenet. 13, 16.
Guerreiro R., Gibbons E., Tábuas-Pereira M., Kun-Rodrigues C., Santo G.C., Bras J. 2020. Genetic architecture of common non-Alzheimer’s disease dementias. Neurobiol. Dis. 142, 104946.
Funding
The present study was supported by the Russian Foundation for Basic Research (project no. 19-115-50415 “Expansion”).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflict of interest.
The present study contains no data on research involving animals as the objects of the study.
The present study contains no data on research involving humans as the objects of the study.
Additional information
Translated by A. Kazantseva
Abbreviations: ASD, autism spectrum disorders; CNS, central nervous system; CIN, chromosome instability; CNV, copy number variations; GIN, genome instability; FISH, fluorescence in situ hybridization; SNP, single nucleotide polymorphism.
Rights and permissions
About this article
Cite this article
Iourov, I.Y., Vorsanova, S.G., Kurinnaia, O.S. et al. Causes and Consequences of Genome Instability in Psychiatric and Neurodegenerative Diseases. Mol Biol 55, 37–46 (2021). https://doi.org/10.1134/S0026893321010155
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893321010155